These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2696215)

  • 1. [Prevention of venous thromboses with oral anticoagulants].
    Hach-Wunderle V; Scharrer I
    Wien Med Wochenschr; 1989 Dec; 139(23):559-62. PubMed ID: 2696215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems of long-term therapy with anticoagulants].
    Lechner K; Gaiger A; Fritz A; Kyrle P; Eichinger S; Pabinger I
    Acta Med Austriaca; 1992; 19(1):21-4. PubMed ID: 1585783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral anticoagulant therapy--renaissance of an old therapy?].
    Lechner K; Korninger C; Kyrle P; Geissler K; Niessner H; Pabinger I; Panzer S; Gössinger H; Bettelheim P; Hinterberger W
    Wien Klin Wochenschr; 1987 Apr; 99(7):203-10. PubMed ID: 3590801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "therapeutic range" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations.
    Bailey EL; Harper TA; Pinkerton PH
    Can Med Assoc J; 1971 Nov; 105(10):1041-3 passim. PubMed ID: 5150206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
    Katona A; Márk L
    Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of recurrence of thromboembolic disease: maintenance of anticoagulant therapy].
    Enrico JF
    Ther Umsch; 1989 Oct; 46(10):732-8. PubMed ID: 2814910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of laboratory monitoring in oral anticoagulant therapy].
    D'Angelo G; Calvano D; Giardini C
    Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factors influencing activity of oral anticoagulants. Interactions with drugs and food].
    Sawicka-Powierza J; Rogowska-Szadkowska D; Ołtarzewska AM; Chlabicz S
    Pol Merkur Lekarski; 2008 May; 24(143):458-62. PubMed ID: 18634396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The perioperative management of warfarin therapy.
    Ansell JE
    Arch Intern Med; 2003 Apr; 163(8):881-3. PubMed ID: 12719195
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral anticoagulant therapy: clinical aspects].
    Marisavljević D
    Srp Arh Celok Lek; 2007; 135(5-6):352-9. PubMed ID: 17633328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative management of patients receiving oral anticoagulants.
    Kearon C; Hirsh J
    Arch Intern Med; 2003 Nov; 163(20):2532-3; author reply 2533. PubMed ID: 14609792
    [No Abstract]   [Full Text] [Related]  

  • 16. [International normalized ratio (INR) for optimal anticoagulant therapy].
    Uetsuka Y; Katsuki T; Aosaki M; Iwade K; Hashimoto A; Koyanagi H; Saito M; Yaginuma Y; Hosoda S
    Kokyu To Junkan; 1993 Sep; 41(9):885-90. PubMed ID: 8210749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
    Torn M; van der Meer FJ; Rosendaal FR
    Arch Intern Med; 2004 Mar; 164(6):668-73. PubMed ID: 15037497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral anticoagulant prophylaxis and epidural catheter removal.
    Wu CL; Perkins FM
    Reg Anesth; 1996; 21(6):517-24. PubMed ID: 8956387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene.
    Eichinger S; Minar E; Hirschl M; Bialonczyk C; Stain M; Mannhalter C; Stümpflen A; Schneider B; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Jan; 81(1):14-7. PubMed ID: 10348706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.